Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9090 Wilshire Blvd
Ste 200
Beverly Hills, CA 90211Phone+1 310-888-8680Fax+1 310-888-1886- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1994 - 1997
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1994
Certifications & Licensure
CA State Medical License 1995 - 2025
MI State Medical License 2001 - 2002- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
Publications & Presentations
PubMed
- Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-...Carla Biesdorf, Xiaowen Guan, Satya R Siddani, Nils Boehm, Bruno C Medeiros, Toshihiko Doi, Maja de Jonge, Drew Rasco, Rajeev M Menon, Akshanth R Polepally, David Hoffman> ;Cancer Chemotherapy and Pharmacology. 2024 Apr 1
- 22 citationsA phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.Amer M Zeidan, Uma Borate, Daniel A Pollyea, Andrew M Brunner, Fernando Roncolato, Jacqueline S Garcia, Robin Filshie, Olatoyosi Odenike, Anne Marie Watson, Ravitharan...> ;American Journal of Hematology. 2023 Feb 1
- 7 citationsDesign of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia.Vladimir Ivanov, Su-Peng Yeh, Jiri Mayer, Lalit Saini, Ali Unal, Michael Boyiadzis, David M Hoffman, Kingston Kang, Sadiya N Addo, Wellington L Mendes, Amir T Fathi> ;Future Oncology. 2022 Aug 1
- Join now to see all
Press Mentions
- Safety and Efficacy of Telatinib in Combination with Keytruda in Subjects with Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular CarcinomaMarch 15th, 2021
- March Is the Month to Get to the Bottom of Colorectal CancerMarch 3rd, 2021
Professional Memberships
- Member
Hospital Affiliations
Cedars-Sinai Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
